rs147219060

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001848.3(COL6A1):​c.2130G>A​(p.Thr710Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00381 in 1,597,108 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0039 ( 31 hom. )

Consequence

COL6A1
NM_001848.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.49

Publications

2 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • collagen 6-related myopathy
    Inheritance: SD, AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 21-46002281-G-A is Benign according to our data. Variant chr21-46002281-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93848.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.49 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0029 (442/152342) while in subpopulation SAS AF = 0.0122 (59/4832). AF 95% confidence interval is 0.00972. There are 3 homozygotes in GnomAd4. There are 234 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001848.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A1
NM_001848.3
MANE Select
c.2130G>Ap.Thr710Thr
synonymous
Exon 32 of 35NP_001839.2P12109

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A1
ENST00000361866.8
TSL:1 MANE Select
c.2130G>Ap.Thr710Thr
synonymous
Exon 32 of 35ENSP00000355180.3P12109
COL6A1
ENST00000498614.5
TSL:1
n.364G>A
non_coding_transcript_exon
Exon 3 of 6
COL6A1
ENST00000612273.2
TSL:5
c.255G>Ap.Thr85Thr
synonymous
Exon 3 of 7ENSP00000483630.2A0A087X0S5

Frequencies

GnomAD3 genomes
AF:
0.00292
AC:
445
AN:
152224
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0126
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00391
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00397
AC:
836
AN:
210700
AF XY:
0.00490
show subpopulations
Gnomad AFR exome
AF:
0.000549
Gnomad AMR exome
AF:
0.00144
Gnomad ASJ exome
AF:
0.00272
Gnomad EAS exome
AF:
0.000126
Gnomad FIN exome
AF:
0.000949
Gnomad NFE exome
AF:
0.00404
Gnomad OTH exome
AF:
0.00432
GnomAD4 exome
AF:
0.00391
AC:
5646
AN:
1444766
Hom.:
31
Cov.:
35
AF XY:
0.00432
AC XY:
3104
AN XY:
717814
show subpopulations
African (AFR)
AF:
0.000600
AC:
20
AN:
33312
American (AMR)
AF:
0.00153
AC:
65
AN:
42434
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
76
AN:
25758
East Asian (EAS)
AF:
0.000231
AC:
9
AN:
39034
South Asian (SAS)
AF:
0.0130
AC:
1097
AN:
84208
European-Finnish (FIN)
AF:
0.00143
AC:
69
AN:
48102
Middle Eastern (MID)
AF:
0.00911
AC:
52
AN:
5708
European-Non Finnish (NFE)
AF:
0.00368
AC:
4071
AN:
1106394
Other (OTH)
AF:
0.00313
AC:
187
AN:
59816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
390
780
1171
1561
1951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00290
AC:
442
AN:
152342
Hom.:
3
Cov.:
34
AF XY:
0.00314
AC XY:
234
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41580
American (AMR)
AF:
0.00359
AC:
55
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.0122
AC:
59
AN:
4832
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10630
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00391
AC:
266
AN:
68016
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00407
Hom.:
0
Bravo
AF:
0.00258
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
1
Bethlem myopathy 1A (1)
-
-
1
Collagen 6-related myopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
4.1
DANN
Benign
0.73
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147219060; hg19: chr21-47422195; API